Dow: Iran Margin Benefits Can Endure (NYSE:DOW)

seekingalpha.com · 2026-10-22

Dow (DOW) remains a buy as strong pricing power and supply disruptions drive robust EBITDA and free cash flow generation.

TickrTrends take: Dow Chemical's potential margin benefits from reduced Iranian competition could provide support for profitability metrics that investors monitoring valuation should track against current Basic Materials sector multiples. As a company trading at an undervalued assessment according to TickrTrends, any sustained margin improvement from geopolitical shifts would warrant observation to determine whether current pricing adequately reflects the company's earnings power. Valuation-focused investors should monitor how these operational benefits flow through to financial results and whether they narrow the gap between current market pricing and intrinsic value estimates.

Read the full story at seekingalpha.com →